No Data
No Data
Emerging markets stock digest: Jelbins significantly extended, Rainfall Sunlight hit the daily limit
<150A> JSH 621 -1 deadlock. It has been announced that a new branch of the home medical care business, 'Visiting Nurse Station Cordiale Edogawa Sales Office,' has been established in Edogawa-ku, Tokyo. 'Visiting Nurse Station Cordiale' is a psychiatric home visit medical support service office. The number of psychiatric patients is increasing year by year, and the demand for home medical care that can be received at home is expanding, so efforts are being made to expand the area. <206A> PRISMBio 415 -39
JSH--Significant rebound, opening a new base for home medical care business in Edogawa Ward, Tokyo.
Sharply rebounded. Selling took the lead in the morning, but later on, buying has become dominant. It has been announced that a new base for home medical care, the 'Visiting Nursing Station Cordiale Edo Office,' has been established in Edogawa-ku, Tokyo. 'Visiting Nursing Station Cordiale' is a psychiatric home visit support service office. The number of psychiatric patients is increasing year by year, and the demand for home medical care that can be received at home is expanding, prompting area expansion.
JSH Research Memo (9): Prioritize the enhancement of internal reserves in the near term and continue with no dividends.
The shareholder return policy JSH <150A> positions shareholder return as one of the important management issues, however, as of the end of March 2024, the retained earnings are in a deficit of 4.32 billion yen. Therefore, it is necessary to continue with no dividends for the time being in order to enhance corporate value through the strengthening of retained earnings. While there is a high possibility that the retained earnings will turn positive by the end of March 2027, the policy is to determine the timing of dividend initiation comprehensively based on performance, financial situation, fund needs, etc. (Writing)
JSH Research Memo (7): It is expected that the performance for the fiscal year ending in March 2025 will continue to grow by double digits, driven by support for employing persons with disabilities.
In the fiscal year ending March 2025, the revenue increased by 18.1% year-on-year to 41.11 billion yen, operating profit increased by 24.2% to 2.58 billion yen, ordinary profit increased by 31.5% to 2.56 billion yen, net income increased by 32.6% to 1.92 billion yen, achieving double-digit growth in both revenue and profit, and is expected to achieve the highest performance in history.
JSH Research Memo (6): Funds raised through the stock listing will be used for growth investment.
■ Performance trends of JSH<150A> 2. Financial condition and management indicators As of the end of March 2024, the financial position shows that the total assets increased by 546 million yen compared to the previous period to 2,539 million yen. Current assets increased by 393 million yen due to capital increase associated with stock listing, cash and deposits, as well as accounts receivable and contract assets increased by 104 million yen. Fixed assets increased by 46 million yen due to the establishment of a new farm, etc. Total liabilities increased by 44 million yen from the previous period to 705 million yen. Interest-bearing liabilities
JSH Research Memo (5): The performance for the fiscal year ending in March 2024 is expected to reach a new record high, excluding net income.
■Performance trends of JSH<150A> 1. Summary of performance for the fiscal year ending March 2024 The performance for the fiscal year ending March 2024 showed a 17.3% increase in revenue to 34,820 million yen compared to the previous year, a 26.5% increase in operating profit to 2,080 million yen, a 21.2% increase in ordinary profit to 1,940 million yen, and a 22.6% decrease in net income to 1,450 million yen. Although the net income decreased due to the occurrence of tax burden, revenue, operating profit, and ordinary profit all reached their highest levels in history, driven by the growth of regional revitalization business. The company
No Data
No Data